Lippi Systems (526604)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price ₹18 is at a 29% discount to book value of ₹25.28 (P/B 0.71), offering a possible asset cushion.
• With a P/E of 7.97 and market cap of only ₹13 Cr, the valuation is optically cheap if any earnings quality can be established.
• Reported ROE of 19.25% and Piotroski F-Score of 5/9 indicate some financial resilience, even if quarterly profit is non-core.
• Latest quarter's ₹5 Cr net profit on zero sales could reflect cash generation from asset sale or investment, needing scrutiny.

Concerns

• Latest quarter sales are ₹0 Cr; there is no visible operating business or revenue engine.
• ROCE of -4.88% shows core operations are loss-making; the positive ROE is driven by non-operating items.
• Profit growth of 1000% and PEG of 0.01 are misleading with a zero-sales quarter; one-off earnings may not recur.
• Price ₹18 is below the stated 52-week low of ₹20.50; promoter holding and dividend data are absent, indicating poor disclosure.

AI Analysis

I have never been seduced by a low price tag alone, and Lippi Systems tests that discipline. At ₹18, the market cap is just ₹13 crore and the stock trades at 0.71 times book value against a book of ₹25.28. A Graham value hunter sees a possible asset cushion; a Buffett owner-operator sees no evidence of a business. The latest quarter shows sales of zero rupees and a net profit of ₹5 crore. Profit growth of 1000% sounds magical, but zero sales tells me this is not operating earnings; it is likely non-recurring income. ROCE is -4.88%. In plain language, the productive operations are losing money, and the healthy-sounding ROE of 19.25% is an artificial result of non-operating items. The P/E of 7.97 and PEG of 0.01 are therefore statistical illusions, not a cheap entry into a compounding machine. This is a micro-cap with insufficient data. Promoter holding is not available, the dividend yield is zero, and the FairStock score refuses to give an opinion. The 52-week range reaches ₹77.50, yet the current price is below the stated 52-week low of ₹20.50. That kind of dislocation is a red flag, not an opportunity, unless I can verify assets and understand why prices collapsed. Benjamin Graham would say: price is what you pay, value is what you get. Here, I cannot measure value with confidence. The Piotroski score of 5 out of 9 implies ordinary financial health, but with no sales, ordinary is not good enough. If the ₹5 crore quarterly profit is from selling an asset or an exceptional receipt, minority shareholders like me may not see the cash. I would demand clarity on the balance sheet, core order book, and management's intentions. At this price, it is a speculative asset play, not a wonderful business at a fair price. I will keep it on my watchlist, but I cannot call it a buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer